ArticleTranslational psychiatry2026
Development and validation of a precision treatment rules for first-line antipsychotic recommendations in first episode psychosis jointly incorporating effectiveness, side effects and patient preferences.
Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Conditional Acceptance and the Optimism-Knowledge Gap: A Scoping Review of Attitudes and Perceptions of Artificial Intelligence in Healthcare in Italy.Medical sciences (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Selecting first-line antipsychotic medication for first episode of psychosis patients is a very challenging task requiring the clinicians to empirically weight multiple criteria. Precision treatment rules developed using health records offer a pragmatic approach to support clinicians' treatment selection, however, they don't incorporate side effects and patient preferences. We used Electronic Health Records from Early Intervention for Psychosis services in South London and the Maudsley NHS Trust and followed the RECORD and TRIPOD + AI guidelines. Precision treatment rules were developed using causal machine learning methods and estimated effectiveness (change of medication, hospitalisation) and side effects (extrapyramidal side effects, hyperprolactinemia, sedation, sexual side effects, and weight gain) using clinical, demographic, symptom and substance use predictors. Patient preferences regarding side effects were incorporated by ranking method. 1709 patients (mean age 26.7 years and 64% male) were included. Aripiprazole was recommended to between 80 and 98% of patients depending on selected patients' preferences. Compared to the observed treatment decisions we estimated that under treatment rules recommendations hyperprolactinemia would be reduced by 4.7 percentage points (pp), sedation by 15.8 pp, sexual side effects by 4.3 pp and weight gain by 15.2 pp with no change in hospitalisation and change of medications outcomes. However, extrapyramidal side effects were estimated to increase by 5.5 pp. This study presents the first precision treatment rules for early psychosis that integrate effectiveness, side effects and patient preferences. Further research using larger data sets, more predictors and treatment options is suggested.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.